Breaking News Instant updates and real-time market news.

2021-01-19 16:04:45 NFLX Netflix $500.78 / +2.83 (+0.57%) 16:04 01/19/21 01/19 16:04 01/19/21 16:04	Netflix up 7% after Q4 results, Q1 guidance Shares of Netflix are up $36.23, or 7%, to $538.00 in afterhours trading following the company's Q4 investor letter.	19 Jan
NFLX Netflix $500.78 / +2.83 (+0.57%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 Citi Citi cuts Spotify to Sell with no benefit seen on podcast investments 01/15/21 Piper Sandler Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler 01/14/21 Barclays Netflix could add 90M Asia-Pacific subs in five years, says Barclays

2021-01-19 16:04:45

NFLX

Netflix

$500.78 / +2.83 (+0.57%)

16:04

01/19/21

01/19

16:04

01/19/21

16:04

Netflix up 7% after Q4 results, Q1 guidance

Shares of Netflix are up $36.23, or 7%, to $538.00 in afterhours trading following the company's Q4 investor letter.

19
Jan

NFLX Netflix

$500.78 / +2.83 (+0.57%)

01/19/21 JPMorgan: JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'

01/15/21 Citi: Citi cuts Spotify to Sell with no benefit seen on podcast investments

01/15/21 Piper Sandler: Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler

01/14/21 Barclays: Netflix could add 90M Asia-Pacific subs in five years, says Barclays

TODAY'S FREE FLY STORIES

Earnings	Teekay Tankers reports Q4 adjusted EPS ($1.21), consensus (99c) » 05:32 02/25/21 02/25 05:32 02/25/21 05:32 TNK Teekay Tankers $13.36 / +0.36 (+2.77%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TNK Teekay Tankers $13.36 / +0.36 (+2.77%) 01/29/21 Jefferies Teekay Tankers price target lowered to $17 from $20 at Jefferies 08/14/20 BofA Teekay Tankers double-downgraded to Underperform from Buy at BofA 06/02/20 Fearnley Teekay Tankers downgraded to Hold from Buy at Fearnley 05/28/20 DNB Markets Teekay Tankers upgraded to Buy from Hold at DNB Markets TNK Teekay Tankers $13.36 / +0.36 (+2.77%) 11/12/20 Teekay Tankers reports Q3 adj. EPS 9c, consensus 19c 12:00 Today Teekay Tankers - TNK
Downgrade	Red Electrica downgraded to Hold from Buy at Kepler Cheuvreux » 05:31 02/25/21 02/25 05:31 02/25/21 05:31 RDEIY Red Electrica $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RDEIY Red Electrica $0.00 / + (+0.00%) 02/22/21 JPMorgan Red Electrica price target lowered to EUR 17.30 from EUR 18 at JPMorgan 02/16/21 Morgan Stanley Red Electrica price target lowered to EUR 15 from EUR 16 at Morgan Stanley 02/12/21 UBS Red Electrica initiated with a Neutral at UBS 02/11/21 Barclays Red Electrica price target lowered to EUR 15.30 from EUR 16 at Barclays
Upgrade	Iberdrola upgraded to Buy from Hold at Kepler Cheuvreux » 05:31 02/25/21 02/25 05:31 02/25/21 05:31 IBDRY Iberdrola $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IBDRY Iberdrola $0.00 / + (+0.00%) 02/12/21 UBS Iberdrola price target raised to EUR 13.20 from EUR 12 at UBS 01/12/21 Barclays Iberdrola price target raised to EUR 14 from EUR 12 at Barclays 01/12/21 Deutsche Bank Iberdrola price target raised to EUR 13 from EUR 11.50 at Deutsche Bank 11/20/20 Credit Suisse Iberdrola price target raised to EUR 11.20 from EUR 9.70 at Credit Suisse
Upgrade	Arjo upgraded to Buy from Hold at SEB Equities » 05:28 02/25/21 02/25 05:28 02/25/21 05:28 ARRJF Arjo $0.00 / + (+0.00%) SEB Equities analyst Carl… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARRJF Arjo $0.00 / + (+0.00%) 01/27/21 SEB Equities Arjo downgraded to Hold from Buy at SEB Equities 01/25/21 Pareto Arjo downgraded to Hold from Buy at Pareto 01/20/21 Nordea Arjo downgraded to Sell from Hold at Nordea
Earnings	Teekay LNG reports Q4 adjusted EPS 61c, consensus 61c » 05:27 02/25/21 02/25 05:27 02/25/21 05:27 TGP Teekay LNG $13.76 / +0.445 (+3.34%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TGP Teekay LNG $13.76 / +0.445 (+3.34%) 01/29/21 Jefferies Teekay LNG price target raised to $14 from $12 at Jefferies 09/16/20 B. Riley FBR Teekay LNG initiated with a Buy, $13 price target at B. Riley FBR 09/15/20 B. Riley FBR Teekay LNG initiated with a Buy at B. Riley FBR TGP Teekay LNG $13.76 / +0.445 (+3.34%) 11/12/20 Teekay LNG reports Q3 adj. EPS 59c, consensus 56c 13:00 Today Teekay LNG - TGP

Downgrade	Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley » 05:27 02/25/21 02/25 05:27 02/25/21 05:27 EPZM Epizyme $10.21 / -0.19 (-1.83%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $10.21 / -0.19 (-1.83%) 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 10/07/20 Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications EPZM Epizyme $10.21 / -0.19 (-1.83%) 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view 12/21/20 Jefferies Epizyme downgraded to Hold from Buy at Jefferies 11/09/20 Barclays Epizyme price target lowered to $18 from $33 at Barclays EPZM Epizyme $10.21 / -0.19 (-1.83%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $10.21 / -0.19 (-1.83%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $10.21 / -0.19 (-1.83%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 03/01/21 41st Annual Healthcare Virtual Conference
Upgrade	CME Group upgraded to Overweight from Equal Weight at Wells Fargo » 05:27 02/25/21 02/25 05:27 02/25/21 05:27 CME CME Group $200.75 / +2.15 (+1.08%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CME CME Group $200.75 / +2.15 (+1.08%) 02/23/21 CME Group Kometer sells almost $1.6M in shares 02/08/21 CME Group announces launch of Ether futures 02/02/21 CME Group reached ADV of 19.2M contracts in January 01/26/21 CME Group to launch Global Emissions Offset contract on March 1 CME CME Group $200.75 / +2.15 (+1.08%) 02/11/21 Citi CME Group price target lowered to $207 from $210 at Citi 01/15/21 Oppenheimer CME Group downgraded to Perform on valuation at Oppenheimer 01/15/21 Oppenheimer CME Group downgraded to Perform from Outperform at Oppenheimer 01/12/21 Barclays CME Group price target raised to $215 from $200 at Barclays CME CME Group $200.75 / +2.15 (+1.08%) 02/10/21 CME Group reports Q4 adjusted EPS $1.39, consensus $1.36 02/09/21 Notable companies reporting before tomorrow's open 02/09/21 Notable companies reporting before tomorrow's open 10/28/20 CME Group reports Q3 adjusted EPS $1.38, consensus $1.41 CME CME Group $200.75 / +2.15 (+1.08%) 02/01/21 CME raises Silver futures margins by 18% to curb volatility, Bloomberg says 09/23/20 Nasdaq, CME plan to launch water futures contract this year, WSJ reports CME CME Group $200.75 / +2.15 (+1.08%) 02/05/21 The Intersection: Crypto and Wall Street This Week 09/11/20 SunPower, Domino's Pizza upgrades among today's top calls on Wall Street CME CME Group $200.75 / +2.15 (+1.08%) 09/29/20 CME Group put volume heavy and directionally bearish
Upgrade	LSL Property Services upgraded to Add from Hold at Peel Hunt » 05:26 02/25/21 02/25 05:26 02/25/21 05:26 LSLPF LSL Property Services $0.00 / + (+0.00%) Peel Hunt analyst Sam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	Faurecia SA initiated with a Neutral at Citi » 05:25 02/25/21 02/25 05:25 02/25/21 05:25 FURCF Faurecia SA $0.00 / + (+0.00%) Citi analyst Gabriel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FURCF Faurecia SA $0.00 / + (+0.00%) 11/02/20 RBC Capital Faurecia SA price target raised to EUR 36 from EUR 35 at RBC Capital 09/30/20 Morgan Stanley Faurecia SA price target lowered to EUR 34 from EUR 36 at Morgan Stanley 09/21/20 Oddo BHF Faurecia SA upgraded to Buy from Neutral at Oddo BHF 09/10/20 BofA Faurecia SA upgraded to Buy from Neutral at BofA
Downgrade	Valeo downgraded to Sell from Neutral at Citi » 05:24 02/25/21 02/25 05:24 02/25/21 05:24 VLEEY Valeo $0.00 / + (+0.00%) Citi analyst Gabriel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VLEEY Valeo $0.00 / + (+0.00%) 02/22/21 Berenberg Valeo price target raised to EUR 39 from EUR 37 at Berenberg 02/19/21 Societe Generale Valeo price target raised to EUR 35 from EUR 28 at Societe Generale 02/19/21 Deutsche Bank Valeo price target raised to EUR 28 from EUR 25 at Deutsche Bank 01/27/21 Berenberg Valeo price target raised to EUR 37 from EUR 34 at Berenberg

Downgrade	Taiheiyo Cement downgraded to Neutral from Buy at Mizuho » 05:22 02/25/21 02/25 05:22 02/25/21 05:22 THYCY Taiheiyo Cement $0.00 / + (+0.00%) Mizuho analyst Hiroshi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	Nike upgraded to Buy from Hold at HSBC » 05:22 02/25/21 02/25 05:22 02/25/21 05:22 NKE Nike $135.79 / -0.35 (-0.26%) HSBC analyst Erwan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKE Nike $135.79 / -0.35 (-0.26%) 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/01/21 Nike announces Nike GO FlyEase hands-free shoe 01/27/21 Columbia Sportswear names Skip Potter as Chief Digital Information Officer 12/18/20 Nike says experienced 80% growth in Nike digital this quarter NKE Nike $135.79 / -0.35 (-0.26%) 02/05/21 Citi Foot Locker upgraded to Buy from Neutral at Citi 02/05/21 Citi Citi sees 'many reasons' for why Nike should acquire Foot Locker 02/03/21 Jefferies Under Armour price target raised to $25 from $23 at Jefferies 01/25/21 KeyBanc Nike price target raised to $180 from $174 at KeyBanc NKE Nike $135.79 / -0.35 (-0.26%) 12/18/20 Nike raises FY21 revenue growth view to low teens 12/18/20 Nike reports Q2 inventories $6.1B, down 2% 12/18/20 Nike reports Q2 NIKE Brand revenue $10.7B, up 8% 12/18/20 Nike reports Q2 NIKE Direct sales $4.3B, up 32% NKE Nike $135.79 / -0.35 (-0.26%) 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports NKE Nike $135.79 / -0.35 (-0.26%) 02/09/21 Fly Intel: What to watch in Under Armour earnings report 02/05/21 Citi says buy Foot Locker, sees 'many reasons' why Nike should too 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 03/18/21 Nike - NKE NKE Nike $135.79 / -0.35 (-0.26%) 12/21/20 Early notable gainers among liquid option names on December 21st 12/18/20 Nike options imply 8.7% move in share price post-earnings 11/10/20 Nike call volume above normal and directionally bullish 09/24/20 Unusually active option classes on open September 24th
Earnings	NetEase reports Q4 EPS 36c, consensus 45c » 05:21 02/25/21 02/25 05:21 02/25/21 05:21 NTES NetEase $117.62 / -2.69 (-2.24%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NTES NetEase $117.62 / -2.69 (-2.24%) 09/18/20 NetEase announces ADS ratio change of five-for-one 09/16/20 NetEase Cloud Music enters strategic partnership with BMG 09/02/20 India bans 118 Chinese mobile apps, including Alipay and Baidu NTES NetEase $117.62 / -2.69 (-2.24%) 02/16/21 Barclays NetEase price target raised to $155 from $110 at Barclays 12/31/20 NetEase initiated with an Outperform at Industrial Securities 11/02/20 Goldman Sachs NetEase price target raised to $107 from $104 at Goldman Sachs 10/07/20 Citi NetEase price target lowered to $106 from $112.60 at Citi NTES NetEase $117.62 / -2.69 (-2.24%) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 11/19/20 NetEase reports Q3 adj. EPS 64c, consensus 39c NTES NetEase $117.62 / -2.69 (-2.24%) 12/12/20 Delisting Chinese companies bad for investors, right thing to do, Barron's says NTES NetEase $117.62 / -2.69 (-2.24%) 11/19/20 Fly Intel: Pre-market Movers 07:00 Today NetEase - NTES NTES NetEase $117.62 / -2.69 (-2.24%) 01/11/21 NetEase put volume heavy and directionally bearish 12/02/20 NetEase put volume heavy and directionally bearish 10/05/20 Notable open interest changes for October 5th
Upgrade	Dixons Carphone upgraded to Buy from Hold at Investec » 05:21 02/25/21 02/25 05:21 02/25/21 05:21 DSITF Dixons Carphone $0.00 / + (+0.00%) Investec analyst Benedict… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DSITF Dixons Carphone $0.00 / + (+0.00%) 01/18/21 RBC Capital Dixons Carphone upgraded to Outperform from Sector Perform at RBC Capital 12/17/20 Barclays Dixons Carphone price target raised to 145 GBp from 120 GBp at Barclays 10/16/20 RBC Capital Dixons Carphone upgraded to Sector Perform from Underperform at RBC Capital 09/04/20 Exane BNP Paribas Dixons Carphone downgraded to Neutral from Outperform at Exane BNP Paribas
Upgrade	NXP Semiconductors upgraded to Buy from Neutral at Citi » 05:19 02/25/21 02/25 05:19 02/25/21 05:19 NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) Citi analyst Christopher… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/17/21 NXP Semiconductors idles manufacturing at two Austin facilities 02/12/21 NXP Semiconductors' Wuamett sells 2,697 common shares 02/03/21 NXP Semiconductors announces EdgeLock 2GO IoT services platform 12/09/20 NXP Semiconductors' Owen sells over 7,000 common shares NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/17/21 Wells Fargo Wells says NXP plants in Austin make up less than 30% of production sq. footage 02/03/21 Fly Intel: Top five analyst upgrades 02/03/21 NXP Semiconductors price target raised to $223 from $200 at Needham 02/03/21 Credit Suisse NXP Semiconductors price target raised to $215 from $175 at Credit Suisse NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/01/21 NXP Semiconductors sees Q1 revenue $2.48B-$2.55B, consensus $2.31B 02/01/21 NXP Semiconductors reports Q4 EPS $1.08, consensus $2.10 10/26/20 NXP Semiconductors reports Q3 EPS (8c) vs. 38c a year ago 10/26/20 NXP Semiconductors sees Q4 adjusted operating income $692M-$766M NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/17/21 Samsung, NXP, Infineon have power shut off in Austin, AAS reports NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/01/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 10/26/20 Fly Intel: After-Hours Movers NXPI NXP Semiconductors $186.31 / +5.27 (+2.91%) 02/01/21 NXP Semiconductors options imply 8.7% move in share price post-earnings 10/01/20 NXP Semiconductors put volume heavy and directionally bearish 09/08/20 NXP Semiconductors put volume heavy and directionally bearish 09/04/20 NXP Semiconductors put volume heavy and directionally bearish

Earnings	Youdao reports Q4 EPS (58c), consensus (70c) » 05:18 02/25/21 02/25 05:18 02/25/21 05:18 DAO Youdao $30.20 / +0.695 (+2.36%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options DAO Youdao $30.20 / +0.695 (+2.36%) 02/10/21 Youdao falls -15.2% 11/19/20 Youdao rises 14.4% DAO Youdao $30.20 / +0.695 (+2.36%) 01/04/21 Macquarie Youdao initiated with an Outperform at Macquarie 01/04/21 Macquarie Youdao initiated with an Outperform at Macquarie 10/22/20 Nomura Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38 09/02/20 Fly Intel: Top five analyst downgrades DAO Youdao $30.20 / +0.695 (+2.36%) 11/19/20 Youdao reports Q3 EPS ($1.12), two estimates ($1.18) 11 Feb 06:00 Today Youdao - DAO DAO Youdao $30.20 / +0.695 (+2.36%) 10/28/20 Seven new option listings on October 28th
Upgrade	Suzuki Motor upgraded to Outperform from Neutral at Daiwa » 05:18 02/25/21 02/25 05:18 02/25/21 05:18 SZKMY Suzuki Motor $0.00 / + (+0.00%) Daiwa analyst Eiji… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SZKMY Suzuki Motor $0.00 / + (+0.00%) 10/03/20 Goldman Sachs Suzuki Motor upgraded to Conviction Buy from Buy at Goldman Sachs 08/28/20 Daiwa Suzuki Motor downgraded to Neutral from Outperform at Daiwa 03/17/20 Nomura Instinet Suzuki Motor upgraded to Neutral from Reduce at Nomura Instinet
Downgrade	Solon Eiendom downgraded to Hold from Buy at DNB Markets » 05:17 02/25/21 02/25 05:17 02/25/21 05:17 BNRPF Solon Eiendom $0.00 / + (+0.00%) DNB Markets analyst Simen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	Scor downgraded to Hold from Buy at Commerzbank » 05:16 02/25/21 02/25 05:16 02/25/21 05:16 SCRYY Scor $0.00 / + (+0.00%) Commerzbank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SCRYY Scor $0.00 / + (+0.00%) 01/12/21 Berenberg Scor price target raised to EUR 36 from EUR 32 at Berenberg 12/17/20 Bryan Garnier Scor downgraded to Buy from Conviction Buy at Bryan Garnier 11/30/20 Morgan Stanley Scor price target raised to EUR 36 from EUR 33 at Morgan Stanley 11/18/20 RBC Capital Scor upgraded to Outperform from Sector Perform at RBC Capital
Upgrade	GB Group upgraded to Buy from Hold at Stifel » 05:15 02/25/21 02/25 05:15 02/25/21 05:15 GBGPF GB Group $0.00 / + (+0.00%) Stifel analyst Bridie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GBGPF GB Group $0.00 / + (+0.00%) 10/29/20 Panmure Gordon GB Group upgraded to Buy from Hold at Panmure Gordon 10/20/20 Berenberg GB Group upgraded to Buy from Hold at Berenberg 10/12/20 Citi Citi opens 'positive catalyst watch' on GB Group 10/07/20 Canaccord GB Group upgraded to Buy from Hold at Canaccord

Upgrade	JCR Pharmaceuticals upgraded to Outperform from Neutral at Credit Suisse » 05:14 02/25/21 02/25 05:14 02/25/21 05:14 JCRRF JCR Pharmaceuticals $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	TD Holdings subsidiary granted Dangerous Chemicals Business License » 05:14 02/25/21 02/25 05:14 02/25/21 05:14 GLG TD Holdings $2.44 / +0.14 (+6.09%) TD Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News GLG TD Holdings $2.44 / +0.14 (+6.09%) 02/17/21 TD Holdings signs LOI to acquire digital cloud warehouse software copyrights 12/15/20 TD Holdings enters LOI to acquire Tongdow 12/04/20 TD Holdings issues statement on recent stock volatility
Upgrade	Vestas upgraded to Buy from Neutral at UBS » 05:13 02/25/21 02/25 05:13 02/25/21 05:13 VWDRY Vestas $0.00 / + (+0.00%) UBS analyst Supriya… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research VWDRY Vestas $0.00 / + (+0.00%) 02/11/21 Deutsche Bank Vestas price target lowered to DKK 1,460 from DKK 1,500 at Deutsche Bank 02/08/21 Deutsche Bank Vestas price target lowered to DKK 1,500 from DKK 1,630 at Deutsche Bank 02/08/21 SEB Equities Vestas downgraded to Hold from Buy at SEB Equities 01/15/21 Morgan Stanley Vestas price target raised to DKK 1,099 from DKK 1,066 at Morgan Stanley
Hot Stocks	Xencor, UCLA TDG collaborate to develop XmAb therapeutics » 05:12 02/25/21 02/25 05:12 02/25/21 05:12 XNCR Xencor $48.58 / +0.09 (+0.19%) Xencor and UCLA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings XNCR Xencor $48.58 / +0.09 (+0.19%) 02/23/21 Xencor expects to have cash to fund operations into 2024 01/06/21 Xencor, MD Anderson collaborate to develop antibodies for cancer treatment 12/17/20 Miragen Therapeutics enters license agreement with Xencor for Xtend technology 12/07/20 Xencor in pact with Janssen to discover antibodies to treat prostate cancer XNCR Xencor $48.58 / +0.09 (+0.19%) 02/24/21 Piper Sandler Xencor remains a top pick for 2021 at Piper Sandler 02/24/21 RBC Capital Xencor price target raised to $59 from $48 at RBC Capital 02/24/21 Raymond James Xencor upgraded to Outperform from Market Perform at Raymond James 02/24/21 Barclays Xencor price target raised to $34 from $31 at Barclays XNCR Xencor $48.58 / +0.09 (+0.19%) 02/23/21 Xencor reports Q4 EPS (24c), consensus (38c) 11/05/20 Xencor reports Q3 EPS (22c), consensus (23c)
Upgrade	AstraZeneca upgraded to Buy from Neutral at UBS » 05:11 02/25/21 02/25 05:11 02/25/21 05:11 AZN AstraZeneca $49.17 / +0.81 (+1.67%) UBS analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 AstraZeneca notes U.S. withdrawal of Imfinzi advanced bladder cancer indication 02/18/21 AstraZeneca's Covid vaccine granted approval in Nigeria for emergency use AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/04/21 Piper Sandler Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' 01/22/21 Barclays AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/24/21 Germany to receive 16M AstraZeneca Covid vaccines in Q2, Reuters reports 02/23/21 AstraZeneca: COVID-19 vaccine could receive U.S. EUA by April, Reuters says 02/23/21 AstraZeneca sees missing EU vaccine supply target in Q2, Reuters reports 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday 02/27/21 AAAAI Virtual Annual Meeting 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $49.17 / +0.81 (+1.67%) 02/24/21 AstraZeneca call volume above normal and directionally bullish 02/17/21 AstraZeneca call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th

Events

Earnings calls, analyst events, roadshows and more

DAO
Today at 06:00

Youdao - DAO Conference Calls
MOGU
Today at 06:30

Mogu - MOGU Conference Calls
SUBCY
Today at 07:00

Subsea 7 - SUBCY Conference Calls
NTES
Today at 07:00

NetEase - NTES Conference Calls
MNSO
Today at 07:00

Miniso - MNSO Conference Calls
Today at 07:00

Utilities Industry Meetings
VIPS
Today at 07:30

Vipshop - VIPS Conference Calls
AMRN
Today at 07:30

Amarin - AMRN Conference Calls
LI
Today at 07:30

Li Auto - LI Conference Calls
PWFL
Today at 08:00

PowerFleet - PWFL Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities $4.30-4.40 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair $25.00-26.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA $23.00-24.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James $4.75-5.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim $0.9901 RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen $21.00-21.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc $17.87 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Netflix up 7% after Q4 results, Q1 guidance

TODAY'S FREE FLY STORIES

Get Full Fly Access